Axxcess Wealth Management’s Recursion Pharmaceuticals RXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $207K | Buy |
40,825
+510
| +1% | +$2.58K | ﹤0.01% | 836 |
|
|
2025
Q1 | $213K | Sell |
40,315
-825
| -2% | -$4.36K | 0.01% | 793 |
|
|
2024
Q4 | $278K | Sell |
41,140
-2,744
| -6% | -$18.5K | 0.01% | 690 |
|
|
2024
Q3 | $289K | Buy |
43,884
+1,795
| +4% | +$11.8K | 0.01% | 697 |
|
|
2024
Q2 | $316K | Buy |
42,089
+4,704
| +13% | +$35.3K | 0.01% | 633 |
|
|
2024
Q1 | $373K | Buy |
37,385
+14,388
| +63% | +$143K | 0.01% | 608 |
|
|
2023
Q4 | $227K | Buy |
+22,997
| New | +$227K | 0.01% | 737 |
|